Incidence and Risk Factors for the Development of Invasive Fungal Infection in Patients Diagnosed With Acute Myeloblastic Leukemia (HIFA)
Active, not recruitingOBSERVATIONAL
Enrollment
300
Participants
Timeline
Start Date
January 1, 2015
Primary Completion Date
June 30, 2026
Study Completion Date
October 31, 2026
Conditions
AML
Trial Locations (1)
46026
Hospital Universitario y Politécnico La Fe, Valencia
All Listed Sponsors
lead
Instituto de Investigacion Sanitaria La Fe
OTHER
NCT07060612 - Incidence and Risk Factors for the Development of Invasive Fungal Infection in Patients Diagnosed With Acute Myeloblastic Leukemia (HIFA) | Biotech Hunter | Biotech Hunter